Related references
Note: Only part of the references are listed.Targeting immunoproteasome in neurodegeneration: A glance to the future
Grazia R. Tundo et al.
PHARMACOLOGY & THERAPEUTICS (2023)
Identification of indole-based activators of insulin degrading enzyme
Nicolas Kraupner et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Neuroprotective Effect of Carnosine Is Mediated by Insulin-Degrading Enzyme
Alessia Distefano et al.
ACS CHEMICAL NEUROSCIENCE (2022)
Polymorphism Rs2421943 of the Insulin-Degrading Enzyme Gene and the Risk of Late-Onset Alzheimer's Disease
Omar Sery et al.
CURRENT ALZHEIMER RESEARCH (2022)
Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes
Michalis Michailidis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review
Md. Shofiul Azam et al.
PHARMACEUTICAL RESEARCH (2022)
Possible Role of Insulin-Degrading Enzyme in the Physiopathology of Retinitis Pigmentosa
Alonso Sanchez-Cruz et al.
CELLS (2022)
Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?
Laetitia Lesire et al.
CELLS (2022)
Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme
Karina Abramov-Harpaz et al.
BIOMOLECULES (2022)
Increased levels of insulin-degrading enzyme in patients with type 2 diabetes mellitus
Helena Kullenberg et al.
ENDOCRINE (2022)
Alzheimer's disease and type 2 diabetes mellitus: A systematic review of proteomic studies
Jessica Diniz Pereira et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme
Carlos M. Gonzalez-Casimiro et al.
BIOMEDICINES (2021)
Hydroxypyridinethione Inhibitors of Human Insulin-Degrading Enzyme
Rebecca N. Adamek et al.
CHEMMEDCHEM (2021)
Targeting Insulin-Degrading Enzyme in Insulin Clearance
Malcolm A. Leissring et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
At the Cutting Edge against Cancer: A Perspective on Immunoproteasome and Immune Checkpoints Modulation as a Potential Therapeutic Intervention
Grazia R. Tundo et al.
CANCERS (2021)
Quantitative NMR Study of Insulin-Degrading Enzyme Using Amyloid-β and HIV-1 p6 Elucidates Its Chaperone Activity
Bhargavi Ramaraju et al.
BIOCHEMISTRY (2021)
Insulin-degrading enzyme: an ally against metabolic and neurodegenerative diseases
Luis Sousa et al.
JOURNAL OF PATHOLOGY (2021)
Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
Zenghui Wei et al.
FRONTIERS IN NEUROSCIENCE (2021)
Effects of Fasting and Feeding on Transcriptional and Posttranscriptional Regulation of Insulin-Degrading Enzyme in Mice
Carlos M. Gonzalez-Casimiro et al.
CELLS (2021)
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
G. R. Tundo et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice
Beatriz Merino et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Protein aggregates and proteostasis in aging: Amylin and β-cell function
Michaela Press et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2019)
Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme
Juan Pablo Maianti et al.
NATURE CHEMICAL BIOLOGY (2019)
Substrate-Selective Enzyme Inhibitors
Qian Chu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Diabetic Retinopathy-An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes
Stephen H. Sinclair et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Molecular Determinants of Substrate Specificity in Human Insulin-Degrading Enzyme
Lazaros Stefanidis et al.
BIOCHEMISTRY (2018)
The insulin-degrading enzyme is an allosteric modulator of the 20S proteasome and a potential competitor of the 19S
Diego Sbardella et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Non-syndromic retinitis pigmentosa
Sanne K. Verbakel et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2018)
Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease
Igor V. Kurochkin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Insulin-degrading enzyme is not secreted from cultured cells
Eun Suk Song et al.
SCIENTIFIC REPORTS (2018)
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
Zhening Zhang et al.
ELIFE (2018)
Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice
Pablo Villa-Perez et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
The core sequence of PIF competes for insulin/amyloid β in insulin degrading enzyme: potential treatment for Alzheimer’s disease
Soren Hayrabedyan et al.
Oncotarget (2018)
Resveratrol Sustains Insulin-Degrading Enzyme Activity toward Aβ42
Claire A. Krasinski et al.
ACS OMEGA (2018)
Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update
Erik Portelius et al.
EXPERT REVIEW OF PROTEOMICS (2017)
Alzheimer's disease prevention: from risk factors to early intervention
Marta Crous-Bou et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Multiple functions of insulin-degrading enzyme: a metabolic crosslight?
Grazia R. Tundo et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?
Olga Pivovarova et al.
ANNALS OF MEDICINE (2016)
Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease
Sung Min Son et al.
AUTOPHAGY (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Multiple allosteric sites are involved in the modulation of insulin-degrading-enzyme activity by somatostatin
Grazia R. Tundo et al.
FEBS JOURNAL (2016)
Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease
Melissa A. Schilling
JOURNAL OF ALZHEIMERS DISEASE (2016)
Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus
Wei-Jen Tang
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation
Mohd Waseem Akhtar et al.
NATURE COMMUNICATIONS (2016)
Intravitreal Injection of Proinsulin-Loaded Microspheres Delays Photoreceptor Cell Death and Vision Loss in the rd10 Mouse Model of Retinitis Pigmentosa
Carolina Isiegas et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors
Samer O. Abdul-Hay et al.
ACS CHEMICAL BIOLOGY (2015)
Insulin-degrading enzyme is activated by the C-terminus of α-synuclein
Sandeep K. Sharma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues
Ekaterina G. Kochkina et al.
BIOGERONTOLOGY (2015)
A neglected modulator of insulin-degrading enzyme activity and conformation: The pH
Giuseppe Grasso et al.
BIOPHYSICAL CHEMISTRY (2015)
The insulin degrading enzyme activates ubiquitin and promotes the formation of K48 and K63 diubiquitin
G. Grasso et al.
CHEMICAL COMMUNICATIONS (2015)
Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo
Timothy B. Durham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Immune regulatory and neuroprotective properties of preimplantation factor: From newborn to adult
E. R. Barnea et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution
Diego Sbardella et al.
PLOS ONE (2015)
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice
Rebecca Deprez-Poulain et al.
NATURE COMMUNICATIONS (2015)
Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner
Sandeep K. Sharma et al.
SCIENTIFIC REPORTS (2015)
Association Between Polymorphisms of the Insulin-Degrading Enzyme Gene and Late-Onset Alzheimer Disease
Shitao Wang et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2015)
An Extended Polyanion Activation Surface in Insulin Degrading Enzyme
Eun Suk Song et al.
PLOS ONE (2015)
Reduced insulin clearance and lower insulin-degrading enzyme expression in the liver might contribute to the thrifty phenotype of protein-restricted mice
Luiz F. Rezende et al.
BRITISH JOURNAL OF NUTRITION (2014)
Insulin-Degrading Enzyme Inhibition, a Novel Therapy for Type 2 Diabetes?
Safia Costes et al.
CELL METABOLISM (2014)
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis
Julie Charton et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Metabolism of Cryptic Peptides Derived from Neuropeptide FF Precursors: The Involvement of Insulin-Degrading Enzyme
Giuseppe Grasso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Molecular Dynamics Simulations Reveal a Novel Mechanism for ATP Inhibition of Insulin Degrading Enzyme
Carlos H. B. da Cruz et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
Juan Pablo Maianti et al.
NATURE (2014)
Reduced amyloid- degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models
Anita Stargardt et al.
AGING CELL (2013)
The Type 2 Diabetes-Associated Gene Ide Is Required for Insulin Secretion and Suppression of α-Synuclein Levels in β-Cells
Par Steneberg et al.
DIABETES (2013)
Insulin-degrading Enzyme (IDE) A NOVEL HEAT SHOCK-LIKE PROTEIN
Grazia Raffaella Tundo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Formation of insulin fragments by insulin-degrading enzyme: the role of zinc(II) and cystine bridges
Francesco Bellia et al.
JOURNAL OF MASS SPECTROMETRY (2013)
Optimization of Peptide Hydroxamate Inhibitors of Insulin-Degrading Enzyme Reveals Marked Substrate-Selectivity
Samer O. Abdul-Hay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
MOLECULAR LINKS BETWEEN ALZHEIMER'S DISEASE AND DIABETES MELLITUS
Y. Yang et al.
NEUROSCIENCE (2013)
Proteolytically Inactive Insulin-Degrading Enzyme Inhibits Amyloid Formation Yielding Non-Neurotoxic Aβ Peptide Aggregates
Matias B. de Tullio et al.
PLOS ONE (2013)
Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme
Lauren A. McCord et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Anion Activation Site of Insulin-degrading Enzyme
Nicholas Noinaj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Metal ions affect insulin-degrading enzyme activity
Giuseppe Grasso et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Nitric Oxide Decreases the Enzymatic Activity of Insulin Degrading Enzyme in APP/PS1 Mice
Markus P. Kummer et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Human matrix metalloproteinases: An ubiquitarian class of enzymes involved in several pathological processes
Diego Sbardella et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Metallostasis and amyloid beta-degrading enzymes
Giuseppe Grasso et al.
METALLOMICS (2012)
Somatostatin Modulates Insulin-Degrading-Enzyme Metabolism: Implications for the Regulation of Microglia Activity in AD
Grazia Tundo et al.
PLOS ONE (2012)
Cell-Permeable, Small-Molecule Activators of the Insulin-Degrading Enzyme
Sayali S. Kukday et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Copper(I) and Copper(II) Inhibit Aβ Peptides Proteolysis by Insulin-Degrading Enzyme Differently: Implications for Metallostasis Alteration in Alzheimer's Disease
Giuseppe Grasso et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
Mixed Dimers of Insulin-degrading Enzyme Reveal a Cis Activation Mechanism
Eun Suk Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Ubiquitin Is a Novel Substrate for Human Insulin-Degrading Enzyme
Luis A. Ralat et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
THE USE OF MASS SPECTROMETRY TO STUDY AMYLOID-β PEPTIDES
Giuseppe Grasso
MASS SPECTROMETRY REVIEWS (2011)
Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance
Samer O. Abdul-Hay et al.
PLOS ONE (2011)
Identification of the Allosteric Regulatory Site of Insulysin
Nicholas Noinaj et al.
PLOS ONE (2011)
Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme
Min Ren et al.
EMBO JOURNAL (2010)
Molecular Basis for the Recognition and Cleavages of IGF-II, TGF-α, and Amylin by Human Insulin-Degrading Enzyme
Qing Guo et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Insulin-Degrading Enzyme Binds to the Nonglycosylated Precursor of Varicella-Zoster Virus gE Protein Found in the Endoplasmic Reticulum
J. E. Carpenter et al.
JOURNAL OF VIROLOGY (2010)
Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aβ, and Alzheimer's Disease
Minerva M. Carrasquillo et al.
PLOS ONE (2010)
A Monomeric Variant of Insulin Degrading Enzyme (IDE) Loses Its Regulatory Properties
Eun Suk Song et al.
PLOS ONE (2010)
Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
Malcolm A. Leissring et al.
PLOS ONE (2010)
Insulin Degrading Enzyme Induces a Conformational Change in Varicella-Zoster Virus gE, and Enhances Virus Infectivity and Stability
Qingxue Li et al.
PLOS ONE (2010)
Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation
Crystal M. Cordes et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Insulin-Degrading Enzyme: Structure-Function Relationship and its Possible Roles in Health and Disease
A. Fernandez-Gamba et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Enzyme solid-state support assays: a surface plasmon resonance and mass spectrometry coupled study of immobilized insulin degrading enzyme
Giuseppe Grasso et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2009)
Risk of Incident Alzheimer's Disease in Diabetic Patients: A Systematic Review of Prospective Trials
Daniel Kopf et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Protective Role of Cys-178 against the Inactivation and Oligomerization of Human Insulin-degrading Enzyme by Oxidation and Nitrosylation
Luis A. Ralat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study
Giuseppe Grasso et al.
JOURNAL OF MASS SPECTROMETRY (2009)
Somatostatin: A Novel Substrate and a Modulator of Insulin-Degrading Enzyme Activity
Chiara Ciaccio et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Insulin-degrading enzyme is exported via an unconventional protein secretion pathway
Ji Zhao et al.
MOLECULAR NEURODEGENERATION (2009)
Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening
Christelle Cabrol et al.
PLOS ONE (2009)
The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection
Mir A. Ali et al.
VIROLOGY (2009)
How the binding and degrading capabilities of insulin degrading enzyme are-affected by ubiquitin
Giuseppe Grasso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
A beta-degrading enzymes in Alzheimer's disease
James Scott Miners et al.
BRAIN PATHOLOGY (2008)
Amyloid β-degrading cryptidases:: insulin degrading enzyme, presequence peptidase, and neprilysin
E. Malito et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Increased expression of Aβ degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology
Saila Vepsalainen et al.
NEUROSCIENCE LETTERS (2008)
The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme A biological perspective
Matias B. de Tullio et al.
PRION (2008)
Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE
Behnosh F. Bjork et al.
NEUROBIOLOGY OF AGING (2007)
Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE
Hookang Im et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The insulysin (insulin degrading enzyme) enigma
L. B. Hersh
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread
Qingxue Li et al.
CELL (2006)
Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism
Yuequan Shen et al.
NATURE (2006)
Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic Tg2576 mice with Alzheimer pathology
Maria C. Leal et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition
P Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease:: review and hypothesis
WQ Qiu et al.
NEUROBIOLOGY OF AGING (2006)
Susceptibility of amyloid β peptide degrading enzymes to oxidative damage:: A potential Alzheimer's disease spiral
H Shinall et al.
BIOCHEMISTRY (2005)
Age- and region-dependent alterations in Aβ-degrading enzymes:: implications for Aβ-induced disorders
A Caccamo et al.
NEUROBIOLOGY OF AGING (2005)
ATP effects on insulin-degrading enzyme are mediated primarily through its triphosphate moiety
ES Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria
MA Leissring et al.
BIOCHEMICAL JOURNAL (2004)
Substrate activation of insulin-degrading enzyme (insulysin) - A potential target for drug development
ES Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo
BC Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon 4 allele
DG Cook et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
ATP inhibits insulin-degrading enzyme activity
MC Camberos et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2001)
Degradation of amylin by insulin-degrading enzyme
RG Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Insulin-degrading enzyme exists inside of rat liver peroxisomes and degrades oxidized proteins
M Morita et al.
CELL STRUCTURE AND FUNCTION (2000)
The oligomerization of amyloid β-protein begins intracellularly in cells derived from human brain
DM Walsh et al.
BIOCHEMISTRY (2000)
Share Paper
